학술논문

Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial
Document Type
Article
Source
In The Lancet Respiratory Medicine May 2018 6(5):345-356
Subject
Primary Research
Articles
Language
ISSN
2213-2600